Michael Hubank

13.5k total citations · 2 hit papers
128 papers, 5.2k citations indexed

About

Michael Hubank is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Michael Hubank has authored 128 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Molecular Biology, 26 papers in Oncology and 21 papers in Cancer Research. Recurrent topics in Michael Hubank's work include Cancer Genomics and Diagnostics (15 papers), Acute Lymphoblastic Leukemia research (13 papers) and Gene expression and cancer classification (10 papers). Michael Hubank is often cited by papers focused on Cancer Genomics and Diagnostics (15 papers), Acute Lymphoblastic Leukemia research (13 papers) and Gene expression and cancer classification (10 papers). Michael Hubank collaborates with scholars based in United Kingdom, United States and India. Michael Hubank's co-authors include David G. Schatz, Robin E. Callard, Jaroslav Stark, Martino Barenco, Nabeel A. Affara, Vincent Plagnol, William V. Holt, Alireza Fazeli, Daniel Brewer and Paul Kellam and has published in prestigious journals such as Nature, New England Journal of Medicine and Nucleic Acids Research.

In The Last Decade

Michael Hubank

123 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identifying differences in mRNA expression by representational difference analysis of cDNA

1994 727 citations Michael Hubank, David G. Schatz profile →
Same Exposure but Two Radically Different Responses to Antibiotics: Resilience of the Salivary Microbiome versus Long-Term Microbial Shifts in Feces

2015 322 citations Michael Hubank et al. profile →

Peers

Countries citing papers authored by Michael Hubank

Since Specialization

Citations

This map shows the geographic impact of Michael Hubank's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Hubank with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Hubank more than expected).

Fields of papers citing papers by Michael Hubank

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Hubank. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Hubank. The network helps show where Michael Hubank may publish in the future.

Co-authorship network of co-authors of Michael Hubank

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Hubank. A scholar is included among the top collaborators of Michael Hubank based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Hubank. Michael Hubank is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Challenging the concept of functional high-risk myeloma through transcriptional and genetic profiling 2025 ·Blood ·(unknown), David A. Cairns, Charlotte Pawlyn, (unknown), Eugene B. Ferris, Gordon Cook, Mark T. Drayson, Kevin Boyd, Paula Proszek, Faith E. Davies, Ruth M. de Tute, Matthew Jenner, (unknown), Roger G. Owen, Michael Hubank, Richard S. Houlston, Graham Jackson, Martin Kaiser	0
2	1656TiP The STAMPEDE2 niraparib-abiraterone acetate + prednisolone trial: A phase III, randomised, open-label trial in patients with metastatic prostate cancer (mPC) with a deleterious alteration in a homologous recombination repair (HRR) gene starting androgen deprivation therapy (ADT) 2024 ·Annals of Oncology ·Sarah Howlett, (unknown), Louise Brown, Claire Amos, Peter Dutey‐Magni, (unknown), Laura E. O’Shea, Catherine A. Hogan, Anna Wingate, (unknown), Rosalind A. Eeles, Michael Hubank, Phillip Williams, William Cross, (unknown), Nigel Clarke, (unknown), Nicholas D. James, Emily Grist, (unknown)	1
3	40P MANIFEST: A multiomic profiling platform for immuno-oncology biomarker discovery 2024 ·Immuno-Oncology Technology ·Zayd Tippu, Kok Haw Jonathan Lim, Michael Hubank, Santiago Zelenay, Trevor D. Lawley, A. Strange, Pippa Corrie, Bernadett Szabados, Nicholas C. Turner, (unknown), Manuel Salto‐Tellez, Caroline Dive, Samra Turajlic	1
4	Recurrent FOSL1 rearrangements in desmoplastic fibroblastoma 2022 ·The Journal of Pathology ·(unknown), (unknown), (unknown), John A. Tadross, Matthew W. Fittall, Debbie Hughes, Hongtao Ye, (unknown), Matthew J. Murray, Roberto Tirabosco, Fernanda Amary, Nicholas Coleman, James Watkins, Michael Hubank, Patrick Tarpey, Sam Behjati, Adrienne M. Flanagan	4
5	Response of NOTCH1-Activated Tracheal Adenoid Cystic Carcinoma to the Gamma Secretase Inhibitor Nirogacestat 2021 ·JCO Precision Oncology ·(unknown), (unknown), Michael Hubank, (unknown), Anna Paterson, David Gilligan, Gary J. Doherty	4
6	Telomere elongation through hTERT immortalization leads to chromosome repositioning in control cells and genomic instability in Hutchinson‐Gilford progeria syndrome fibroblasts, expressing a novel SUN1 isoform 2018 ·Genes Chromosomes and Cancer ·(unknown), Richard Faragher, (unknown), Peter Meinke, Alastair Kerr, (unknown), (unknown), (unknown), Eric C. Schirmer, Michael Hubank, Ian R. Kill, Rhona M. Anderson, Predrag Slijepčević, Evgeny M. Makarov, Joanna M. Bridger	15
7	Circulating tumour DNA (ctDNA) as a tool to assess response and guide therapy adaptation in rectal cancer 2018 ·Annals of Oncology ·Shelize Khakoo, (unknown), Nicola Valeri, (unknown), Thomas R. Jones, Ruwaida Begum, Isma Rana, (unknown), Maria Antonietta Bali, Gina Brown, Andrew Wotherspoon, Monica Terlizzo, Katharina von Loga, Imtiaz Ahmed, David Watkins, Ian Chau, Naureen Starling, Diana Tait, Michael Hubank, David Cunningham	1
8	Multiplatform assay to classify formalin-fixed paraffin-embedded (FFPE) colorectal cancer (CRC) samples into molecular subtypes with mutational profiles 2017 ·Annals of Oncology ·Elisa Fontana, Chanthirika Ragulan, David Cunningham, Sanna Hulkki-Wilson, Francesco Sclafani, Gift Nyamundanda, Katherine Eason, Ruwaida Begum, Irene Chong, Clare Peckitt, Maria Antonietta Bali, J. Oates, David Watkins, Shuan Rao, Michael Hubank, Andrew Wotherspoon, Nicola Valeri, Ian Chau, Naureen Starling, Anguraj Sadanandam	1
9	Comprehensive molecular characterisation of epilepsy-associated glioneuronal tumours 2017 ·Acta Neuropathologica ·T. J. Stone, (unknown), Alex Virasami, William Harkness, Martin Tisdall, Elisa Izquierdo, Alice Gutteridge, Tony Brooks, Mark Kristiansen, Jane Chalker, (unknown), William Mifsud, John Apps, Maria Thom, Michael Hubank, Tim Forshew, J. Helen Cross, Darren Hargrave, Jonathan Ham, Thomas S. Jacques	48
10	Neuroblastoma Killing Properties of Vδ2 and Vδ2-Negative γδT Cells Following Expansion by Artificial Antigen-Presenting Cells 2014 ·Clinical Cancer Research ·Jonathan Fisher, Mengyong Yan, (unknown), Lisa Carter, (unknown), (unknown), Rebecca Wallace, Barry Flutter, Anna Capsomidis, Michael Hubank, Nigel Klein, Robin E. Callard, Kenth Gustafsson, John Anderson	88
11	Photoreceptor precursors derived from three-dimensional embryonic stem cell cultures integrate and mature within adult degenerate retina 2013 ·Nature Biotechnology ·Anai Gonzalez-Cordero, Emma L. West, R. A. Pearson, Yanaí Durán, Lívia S. Carvalho, Colin J. Chu, Arifa Naeem, Samuel J.I. Blackford, Anastasios Georgiadis, Jörn Lakowski, Michael Hubank, Alexander J. Smith, James Bainbridge, Jane C. Sowden, Robin R. Ali	283
12	Genome-Wide Analysis of Alternative Splicing in Medulloblastoma Identifies Splicing Patterns Characteristic of Normal Cerebellar Development 2011 ·Cancer Research ·Francesca Menghi, Thomas S. Jacques, Martino Barenco, Ed C. Schwalbe, Steven C. Clifford, Michael Hubank, Jonathan Ham	18
13	Subtype-Specific FBXW7 Mutation and MYCN Copy Number Gain in Wilms' Tumor 2010 ·Clinical Cancer Research ·Richard D. Williams, Reem Al‐Saadi, Tasnim Chagtai, Sergey Popov, Boo Messahel, Neil J. Sebire, Manfred Gessler, Jenny Wegert, Norbert Graf, Ivo Leuschner, Michael Hubank, Chris Jones, Gordan Vujanić, Kathy Pritchard‐Jones, (unknown), (unknown)	55
14	Coordinated oncogenic transformation and inhibition of host immune responses by the PAX3-FKHR fusion oncoprotein 2005 ·The Journal of Experimental Medicine ·Stephen Nabarro, Nourredine Himoudi, (unknown), Kimberly Gilmour, Sian Gibson, Neil J. Sebire, Adrian J. Thrasher, Michael P. Blundell, Michael Hubank, Glenda Canderan, John Anderson	42
15	Up-Regulation of Hlx in Immature Th Cells Induces IFN-γ Expression 2004 ·The Journal of Immunology ·Wei-ping Zheng, Qian Zhao, Xinyan Zhao, Baiyong Li, Michael Hubank, David G. Schatz, Richard A. Flavell	43
16	E4BP4 expression is regulated by the t(17;19)‐associated oncoprotein E2A‐HLF in pro‐B cells 2004 ·British Journal of Haematology ·Jenny Yeung, E. O’Sullivan, Michael Hubank, Hugh J.M. Brady	9
17	Gene expression profiling in childhood acute leukaemia; a useful classification tool and a first promising insight into drug resistance. 2003 ·Blood ·Frederik W. van Delft, Anthony Bellotti, (unknown), Naina Patel, Mark Skinner, Michael Hubank, Ian Hann, (unknown), Jean Sargent, Colin G. Taylor, Alex Gammerman, Vaskar Saha	1
18	From the top down: towards a predictive biology of signalling networks 2003 ·Trends in biotechnology ·Jaroslav Stark, Robin E. Callard, Michael Hubank	34
19	[19] cDNA representational difference analysis: A sensitive and flexible method for identification of differentially expressed genes 1999 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Michael Hubank, David G. Schatz	95
20	DNA-dependent protein kinase is not required for the p53-dependent response to DNA damage 1999 ·Nature ·Gretchen S. Jimenez, (unknown), Maria I. Torres‐Arzayus, Anne Priestley, (unknown), Shinichi Saito, Kazuyasu Sakaguchi, Ettore Appella, Penny A. Jeggo, Guillermo E. Taccioli, Geoffrey M. Wahl, Michael Hubank	112

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact